Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4NJL

Crystal structure of middle east respiratory syndrome coronavirus S2 protein fusion core

Summary for 4NJL
Entry DOI10.2210/pdb4njl/pdb
DescriptorS protein, TRIETHYLENE GLYCOL (3 entities in total)
Functional Keywordssix-helix-bundle, coronavirus, mers-cov, fusion inhibitor, fusion core, viral protein
Biological sourceMiddle East respiratory syndrome coronavirus
Total number of polymer chains1
Total formula weight14195.80
Authors
Zhu, Y.,Lu, L.,Qin, L.,Ye, S.,Jiang, S.,Zhang, R. (deposition date: 2013-11-10, release date: 2014-02-19, Last modification date: 2023-09-20)
Primary citationLu, L.,Liu, Q.,Zhu, Y.,Chan, K.H.,Qin, L.,Li, Y.,Wang, Q.,Chan, J.F.,Du, L.,Yu, F.,Ma, C.,Ye, S.,Yuen, K.Y.,Zhang, R.,Jiang, S.
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor.
Nat Commun, 5:3067-3067, 2014
Cited by
PubMed Abstract: A novel human coronavirus, Middle East respiratory syndrome coronavirus (MERS-CoV), has caused outbreaks of a SARS-like illness with high case fatality rate. The reports of its person-to-person transmission through close contacts have raised a global concern about its pandemic potential. Here we characterize the six-helix bundle fusion core structure of MERS-CoV spike protein S2 subunit by X-ray crystallography and biophysical analysis. We find that two peptides, HR1P and HR2P, spanning residues 998-1039 in HR1 and 1251-1286 in HR2 domains, respectively, can form a stable six-helix bundle fusion core structure, suggesting that MERS-CoV enters into the host cell mainly through membrane fusion mechanism. HR2P can effectively inhibit MERS-CoV replication and its spike protein-mediated cell-cell fusion. Introduction of hydrophilic residues into HR2P results in significant improvement of its stability, solubility and antiviral activity. Therefore, the HR2P analogues have good potential to be further developed into effective viral fusion inhibitors for treating MERS-CoV infection.
PubMed: 24473083
DOI: 10.1038/ncomms4067
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.3 Å)
Structure validation

250059

PDB entries from 2026-03-04

PDB statisticsPDBj update infoContact PDBjnumon